Dr. GPCR Member
Pharmacology data analyst and consultant
Analytical pharmacology ■ Kinetics ■ Signaling ■ GPCR ■ Ligand binding ■ Allosteric modulation
LinkedIn Twitter Website YouTube
Founder & Consultant @ Pharmechanics LLC
Owego, NY, USA
Dr. GPCR Ecosystem Member since August 2020
I am a seasoned GPCR drug discovery scientist, with 15 years of experience in the pharmaceutical industry and a track record in developing new ways to analyze and understand GPCR pharmacology. I am known particularly for applying kinetics to the discovery and development of improved GPCR therapeutics, and for developing new analytical frameworks to quantify signaling kinetics. In 2015, I founded Pharmechanics LLC, a consultancy that provides pharmacology data analysis tools and support and strategic consulting for pharmaceutical, life science, and scientific research organizations.
I am known for demystifying complicated and newly-emerging pharmacology concepts, enabling them to be applied by investigators and project teams to drug discovery and receptor research. I completed postdoctoral training at the National Institute of Mental Health, researching pharmacological mechanisms of Class B GPCRs, and obtained my Ph.D. in biochemistry, studying allosteric modulation of dopamine receptors, from the University of Kent, United Kingdom.
Expertise
Kinetics of binding and signaling
Family B GPCR pharmacology
Analytical pharmacology
Industrial pharmacology
Allosteric modulation
Publications